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ABSTRACT 
 
Population of Tau Embedded in Parallel β-Sheets Depends on Heparin Stoichiometry 
 
by 
 
Zachary Ray Oberholtzer 
 The aggregation of the human tau protein is heavily implicated in the progression of 
Alzhiemer’s Disease.  In this study we examined the aggregation kinetics of a truncated 
segment of the longest tau isoform, Tau 187, and induced aggregation with the polyanion 
hepain.  We applied cw-EPR in order to quantitatively measure the population of tau 
embedded in parallel β-sheet structure and compared these measurements to traditional 
kinetic measurement techniques, Tht fluorescence and turbidity. Cw-EPR revealed rapid 
formation of parallel β-sheet structure early in the aggregation process well before fibrils are 
thought to appear.  We observe a large population of spins first exhibits reduced mobility 
upon mixing with heparin, which is later followed by an increase in β-sheet structure 
consistent with proposed models of nucleation followed by structural rearrangement.  
Additionally, comparing cw-EPR with Tht fluorescence demonstrates Tht binding is non-
linear with respect to parallel β-sheet structure and the precise binding structure of Tht 
remains unclear.   
The transfer of tau pathology from infected to healthy cells has been well established 
by the literature, however, little is known about the relationship between seed structure and 
seeding efficacy.  Here we investigated the importance of β-sheet content as detected by cw-
EPR on seeding efficacy, but were unable to establish a relationship due to the overriding 
v 
effect of heparin.  Previously our group has observed a conformational shift around the 
PHF6* hexapeptide from compact to extended state and we examined the stoichiometric 
effect of heparin on this extension to determine the potency of heparin for inducing changes 
in the tau system.  Finally, dependence of tau aggregation kinetics on heparin stoichiometry 
was investigated.    We discovered the extent of observable distance change depended on 
heparin stoichiometry, however, even dilute quantities of heparin are able to induce 
significant extension around the PHF6* hexapeptide.  The amount of total fibril formation 
was also found to depend on the heparin stoichiometry with lower heparin concentrations 
generating less total fibril content.  Our findings suggests even minute quantities of heparin 
exerts great influence on the tau system and future work will require ways of working around 
or limiting heparin’s influence in order to directly probe the underlying fundamentals of tau 
aggregation.   
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I. Introduction 
Alzheimer’s disease (AD) is the sixth leading cause of death in the United States, 
fifth for the 65 or older age group, and places a heavy burden on society both economically 
and emotionally for those with affected family members.
1
  The aggregation of human tau, an 
intrinsically disordered protein (IDP), is strongly correlated with the progression of AD, in 
which tau fibrils are a hallmark of the disease pathology.    Current therapeutic approaches 
for AD show little effectiveness for improving patient quality of life or arresting disease 
progression, thus improving our understanding of tau aggregation should aid in the 
development of effective treatments.
2, 3
  Until recently the majority of AD research focused 
on amyloid-β, another aggregating protein heavily implicated in AD progression, the 
aggregation of which is generally thought to precede tau aggregation.
4, 5
  Although tau has 
been placed downstream of amyloid-β aggregation evidence suggests tau is critically 
involved in mediating disease toxicity.
6, 7
  Additionally, accumulation of tau aggregates 
correlates strongly with worsening patient condition, whereas accumulation of amyloid-β 
aggregates shows no such correlation.
8
  Meanwhile, even the basic mechanism of tau 
aggregation is not known or agreed upon in the literature. This justifies the importance of 
studying the structural and dynamic properties of early intermediates of tau aggregation. 
2 
 In this study, we focus on the aggregation of peptide and protein fragments of the 
human tau protein. Tau consists of six isoforms all of which are incorporated into fibrils 
during AD progression.  The primary function of tau is binding and stabilizing microtubules, 
which provides structural integrity to the cell.  Each tau isoform contains three or four repeat 
microtubule binding domains which are located in the C-terminus.
9
  The aggregation of tau 
into fibrils is dependent on two hexapeptide motifs, sequence VQIINK (PHF6*) and 
VQIVYK (PHF6), which form the core of the β-sheet structure and are located in the 
microtubule binding region of the protein, Figure 1.
10, 11
  The presence of one of the 
hexapeptides—certain tau isoforms only contain the PHF6 sequence—while critical are 
generally insufficient to promote aggregation at experimentally relevant time scales and the 
forces driving the normally soluble tau monomer to aggregate are unclear, especially in 
vivo.
12
  In solution tau is intrinsically disordered with no overt secondary or tertiary structure, 
while it displays overall low hydrophobic character. The full length tau isoforms exhibit a 
small net charge; however, there are regions of the chain with high charge density, mainly in 
the repeat binding domain.
13
  It is speculated that charge neutralization in the repeat binding 
domain allows for tau assembly; although, it should be noted that charge neutralization by 
adjusting pH is insufficient to induce aggregation at experimentally relevant time scales.
9, 13
  
In order to study tau at experimentally useful time scales generally truncated segments of the 
Figure 1:  Schematic of the Tau 187 segment used in this study.  The Tau187 segment is that of the longest tau 
isoform hTau40 with the n-terminus truncated, spanning the full microtubule binding region (MTBR).  The two 
hexapeptide motifs and their location in the tau sequence are shown. 
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full length isoforms are studied usually containing the microtubule binding regions with at 
least one of PHF6 or PHF6*.  The addition of aggregation inducing cofactors, commonly 
polyanions, is usually required in addition to truncation in order for aggregation to proceed.  
The most common polyanion used in tau aggregation studies is heparin, which aggregates tau 
into fibrils morphologically similar to those found in AD.10, 14, 15  This has led to the wide-
spread usage of heparin in the literature for investigating tau aggregation.  We will also use 
heparin as an initiator of tau aggregation in order to study early aggregation intermediates 
and kinetics of tau peptide and protein fragments. 
The overarching goal of this study is to probe the nature of the aggregate seed and the 
driving force of tau aggregation.  Insight into the interactions between naive tau, early 
aggregates and heparin will provide important clues into potential therapeutic approaches to 
prevent or slow down aggregation.  Tau aggregation typically follows a sigmoidal kinetic 
profile with a distinct lag phase preceding a rapid growth phase which eventually tapers 
culminating with the appearance of mature fibrils, Figure 2.
16
  Considerable study of 
aggregation kinetics has been carried out but in the absence of sufficiently direct probing 
tools the kinetics data of fibril formation gives important, but incomplete insight.  Thioflavin 
T (Tht) is a fluorescent dye sensitive to amyloid structure and has been used to monitor tau 
aggregation kinetics.
17, 18
  Despite its utility Tht cannot provide quantitative or clear 
assessment of β-sheet structure due to unresolved questions about its binding stoichiometry 
and mechanisms.  Rather, Tht offers an empirical metric for assessing the content of certain 
β-sheet species, though the size threshold required for Tht fluorescence activity is unclear. 
The unclear relationship between Tht fluorescence and other kinetic measurements—
such as turbidity—with molecular level structural details necessitates the use of other tools 
4 
Figure 2:  Schematic of typical sigmoidal kinetics of Tau aggregation induced 
with the polyanion heparin.  Initially, little activity is detected followed by 
rapid increase in signal intensity which eventually reaches a maximum. 
for monitoring aggregation.  In this study we turn to continuous wave Electron Paramagnetic 
Resonance (cw-EPR) which through appropriate application can provide quantitative 
population measurements of tau molecules embedded in parallel β-sheet structure and 
additionally can be used to probe the local environment around the attached spin label.
19, 20
  
The application of cw-EPR allows for monitoring of specific structural features during the 
aggregation process including the difficult to detect early intermediates and provides 
population measurements of the total number of spins experiencing any one environment. 
Additionally, comparing cw-EPR measurements with Tht fluorescence will provide a more 
thorough understanding of the precise structural details Tht detects.   
A key concept in tau aggregation is understanding the interaction between tau 
aggregates and tau monomer.  The progression of AD is marked by the systematic and 
predictable spread of tau pathology along interconnected neural pathways.
21, 22
  Multiple 
studies have shown in cell and mouse models that transfer of tau pathology from infected to 
healthy cells, whereby pre-formed aggregate “seeds” enter healthy cells and recruit 
endogenous tau into fibril aggregates, is possible by normal cellular processes.
22-28
  .  While 
this type of seeded aggregation mechanism does not explain the first cause of tau aggregation 
it provides a plausible 
mechanism for the 
propagation of tau and AD 
pathology.  Considerable 
study of seeded 
aggregation has been 
focused in vivo, attempting 
5 
to identify tau oligomers/species which are capable of penetrating cell membranes and 
recruiting endogenous tau into fibril aggregates and elucidating cellular mechanisms of 
internalization and externalization.
23, 28
    Seeded aggregation was demonstrated in vitro 
capable of reducing or eliminating the characteristic lag phase and as well as increasing the 
rate of aggregation.
16, 29, 30
  However, these in vitro studies primarily have used late stage 
fibrils, often sonicated before exposing to naive tau, as the seed material and characterization 
of the seeds used in these studies has been lacking.  While there has been some effort in vivo 
to identify the effect of different oligomer species on recruitment of endogenous tau, it is 
difficult to isolate the fundamental efficacy of oligomers and distinct conformations in 
inducing aggregation irrespective of the confounding effects of cellular process.
23, 28
  We 
would like to approach this question from an in vitro perspective and investigate whether 
certain structural attributes, as measured by cw-EPR, change the interaction between 
aggregates and naïve tau. 
In this work we investigated several characteristics of the tau aggregation process. 
We applied continuous wave Electron Paramagnetic Resonance (cw-EPR) to quantify and 
track the amount of tau population embedded in β-sheet content during aggregation and 
compared to more traditional Tht fluorescence measurements.  Margetti and Langen first 
showed the utility of cw-EPR for analyzing tau fibrils by identifying a signature line shape 
for parallel β-sheet structure, which with proper analysis can be used to determine side-chain 
mobility and quantify % population involved in inter-molecular β-sheet contacts.19 
Additionally, we investigated the relationship between population of tau embedded in β-sheet 
structure, as measured by cw-EPR, and efficacy in recruiting naïve tau to form fibrils.  
Essentially we questioned whether the maturity of tau aggregates impacts the ability of seeds 
6 
to not only template aggregation but to additionally catalyze recruitment of tau monomer into 
fibrils.  Finally, we investigate the stoichiometric role of heparin in inducing conformational 
rearrangement.  Previously, our group has identified a conformational shift around the 
PHF6* hexapeptide from a compact hairpin like structure to an extended conformation upon 
incubation with heparin.  We believe this conformational shift is a key step in the aggregation 
pathway.  Double Electron Electron Resonance (DEER) spectroscopy was employed in order 
to examine conformational rearrangements around the PHF6* hexapeptide when mixed with 
different stoichiometric amounts of heparin.  In this study we apply a combination of 
traditional techniques and the unique spectroscopy tools available to our lab in order to 
examine the early aggregation process and interrogate the effect of pre-formed aggregate 
seeds on naïve tau with the goal of improving understanding of tau aggregation.    
II. Technical Background 
2.1 Thioflavin T Fluorescence 
 Thioflavin T (Tht) has found considerable usage as a fluorescent dye for 
identification of amyloid structure with a relatively high degree of specificity.  The 
predominant hypothesis of Tht binding posits Tht binds within channels created by the amino 
acid side chains involved in β-sheet formation, a prevalent structural component of amyloid. 
These channels run parallel to the long fibril axis of the β-sheet structure.  The binding of Tht 
restricts the rotation of Tht’s benzylamine and benzathiole rings.  The rotation of these two 
rings quenches the excited states of Tht thus by restricting rotation the excited states are 
preserved and a many fold increase in fluorescence is observed.
18
  The Tht fluorescence 
assay provides only a qualitative assessment of the total amount of fibril content.
17
 
2.2 cw-EPR Line Shape Analysis 
7 
 Continuous wave Electron Paramagnetic Resonance (cw-EPR) of proteins singly 
labeled with nitroxide radicals can be used to monitor changes in the protein backbone 
dynamics and the formation of inter-protein contacts.  In this study we use the nitroxide (1-
oxyl-2,2,5,5,-tetramethylpyrroline-3-methyl) methanethiosulfonate (MTSL) and its 
diamagnetic analog (EPR inactive) (1-Acetoxy-2,2,5,5,-tetramethyl-d-3-pyrroline-3-methyl) 
methanethiosulfonate, (dMTSL).  The spin labels are attached to tau via a disulfide bond to 
cysteines selectively located within the amino acid sequence using site directed mutagenesis.  
Through line shape analysis of the EPR spectra individual side-chain mobility and 
quantitative determination of tau population embedded in parallel β-sheet content can be 
investigated.  Singly labeled tau fibrils previously examined by cw-EPR have been shown to 
have spin-exchange broadening, a situation where the electron orbitals of the spin labels are 
close enough (<8Å) to overlap and a characteristic single line component contribution to the 
typical three line nitroxide EPR spectrum is observed, Figure 3A.  The appearance of the 
spin-exchange interaction indicates the tau molecules are stacking in a parallel fashion.
19, 31
  
Validation of this conclusion is completed by spin dilution, mixing paramagnetic (MTSL) 
8 
labeled tau with diamagnetic (dMTSL) tau in 
a 20:80 ratio which eliminates contributions 
from spin-exchange and reduces the effect of 
dipolar broadening, Figure 3B.  As displayed 
in Figure 3 the 100% MTSL labeled tau 
requires a three component fit including a 
single line spin-exchange component which 
is indicative of parallel β-sheet, whereas the 
20:80 spin diluted EPR spectrum only 
requires a two component fit and does not 
include a spin-exchange component.  For 
reference monomeric MTSL labeled tau 
yields a sharp three line nitroxide spectrum 
which can be fit by a purely mobile component.  The interfacial component represents spins 
which suffer reduced mobility but are not experiencing spin-exchange.  Through simulation 
of the collected EPR spectrums the % population of tau involved in parallel β-sheet structure 
can be determined.  The simulations conducted in this study were carried out using the 
Multicomponent software developed by Dr. Christian Altenbach (University of California, 
Los Angeles, CA). 
2.3 DEER Spectroscopy 
Double electron-electron resonance (DEER) can be used to measure distances 
between a pair of paramagnetic spin labels in the range of 1.7-10nm.
32, 33
  Measuring 
distances using pulsed EPR techniques offer enhanced sensitivity compared to scattering 
Figure 3:  A) EPR nitroxide spectra of 100% 
MTSL labeled tau upon aggregation.  Requires a 
three component fit including a spin-exchange 
component in addition to mobile and interfacial 
components. B) EPR nitroxide spectra of 20:80 
ratio MTSL:dMTSL spin labeled tau upon 
aggregation.  Only requires two component fit 
with mobile and interfacial components. 
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techniques and can measure longer distances than Nuclear Magnetic Resonance (NMR) 
which is typically limited to distances within 1nm.
34, 35
  Fluorescence resonance energy 
transfer (FRET) is a popular biological technique for distance measurements and offers 
greater sensitivity compared to DEER, however, the labels used in FRET measurements are 
bulkier than the spin labels available for DEER and thus have a greater risk of perturbing the 
system being studied.  FRET requires the use of two different chromophores, whereas DEER 
can measure distances between either the same type spin label or two different labels and 
labeling protocols can be much more difficult for FRET.
35
  There are a few drawbacks of 
DEER which should be noted namely the need to conduct experiments at cryogenic 
temperatures, which forces the use of glass-forming agents such as glycerol or sucrose, and 
the use of deuterated buffers, which are necessary to extend the spin-spin diffusion time T2 
allowing greater sensitivity and longer distances to be measured.
36
  Carrying out 
measurements at cryogenic temperatures is not necessarily a major disadvantage as it allows 
us to take a snap-shot of the transient aggregation process. 
The pulse sequence used in this study is a four pulse DEER sequence, Figure 4A, 
which has the benefit of eliminating artifacts due to dead time.  In practice DEER consists of 
measuring the amplitude of a refocused echo while sweeping the time placement, 𝑡, of the 
pump pulse, Figure 4A.  The pulses at frequency ωA are the observed channel and induce a 
refocused echo in the spin population affected by the ωA frequency.  The pump pulse at the 
ωB frequency inverts a different spin population which modulates the refocused echo 
intensity at the dipolar frequency.  
The dipolar frequency 𝑣𝑑𝑑 is defined in eqn 1, where g1, g2 are the g values of the two 
spins, 𝜇𝐵 is the bohr magneton, 𝜇0 is the vacuum permeability, θ is the angle between the 
10 
spin-spin vector and the external field and r is the distance separating spins.  In cases where 
there is no orientational selectivity, as should be the case for nitroxide spin labels attached to 
protein, θ is taken to be 90⁰.  The dipolar frequency can be determined from the fast Fourier 
transform of the background corrected trace, Figure 4B, where the dipolar frequency 
2𝑣𝑑𝑑(𝑟, 90°) is extracted from the pake pattern, Figure 4C, and related to the distance by eqn 
2 with the constant values approximated for nitroxide spin labels.   
 𝑣𝑑𝑑(𝜃, 𝑟) =
𝜇0𝑔1𝑔2𝜇𝐵
2ℎ
(3 cos2 𝜃 + 1)
1
𝑟3
  1 
 𝑣𝑑𝑑(𝜃, 𝑟) = √
52.16
𝑣𝑑𝑑(𝑟,90°)
3
 2 
 
Figure 4: A) Pulse program for a 4-pulse DEER experiment.  An initial π/2-pulse is applied at frequency ωA and 
allowed to evolve for time τ1 and then a π-pulse refocuses the spins producing a Han echo.  A pump π-pulse at 
frequency ωB at varying time, t, after the han echo modulates the observed spins.  A final π-pulse at frequency 
ωA refocuses the observed spins producing an echo whose amplitude is measured at time τ2.  B) Background 
corrected DEER experimental output with t corresponding to the position of the pump pulse.  The dipolar 
frequency, 𝑣𝑑𝑑, can be measured from the oscillation frequency.  C) Pake pattern resulting from Fast Fourier 
11 
Transform of the background corrected DEER trace.  Often in real experiments the echo amplitude rapidly 
decays with t thus making oscillations difficult to pull directly from the background corrected trace.   The 
distance between the pake pattern peaks is proportional to 𝑣𝑑𝑑.   
 
III. Methods 
3.1 Protein Expression 
 Purified DNA of Tau 187, Figure 1, consisting of residues 255-441 was transformed 
into E. coli BL21 (DE3) and grown in 10 mL of LB broth (Fisher Scientific) at 37 
o
C with 
shaking. This culture was used to inoculate a fresh 1 L batch of LB and was incubated at 37 
o
C with shaking until it reached an optical density of 0.6-0.8 at A600. Expression of Tau 187 
was then induced by adding 1 mM final isopropyl b-D-thiogalactopyranoside (IPTG, Fisher 
Scientific) and incubated for 3 hours. The bacteria were harvested by centrifugation at 4,500 
x g (Beckman J-10) for 20 min.  
1 Pierce protease inhibitor tablet (Thermo Scientific) and PMSF (1 mM) was added to 
lysis buffer (Tris-HCl, pH=7.4, 100 mM NaCl, 0.5 mM DTT, 0.1 mM EDTA).  Cell pellets 
were dissolved in this mixture and incubated with lysozyme (2 mg mL
-1
), DNase (20 mg mL
-
1
), and MgCl2 (10 mM) and set on ice for 30 min. After lysis cells were sonicated for 20 min 
using a bath sonicator (Laboratory Supplies Co.). Cell debris was removed by centrifugation 
at 10,000 rpm at 4 
o
C for 10 min. The lysate was supplemented with an addition of PMSF (1 
mM) and heated to 65 
o
C for 12 min. The samples were cooled on ice for 20 min and then 
centrifuged as described above to remove the precipitant. The supernatent was loaded onto a 
Ni-NTA agarose column, incubating overnight at 4°C.  The Ni-NTA column was then 
equilibrated in wash buffer A (20 mM sodium phosphate, pH=7.0, 500 mM NaCl, 10 mM 
imidazole, 100 mM EDTA). The column was washed with 20 mL of buffer A, 15 mL buffer 
B (20 mM sodium phosphate, pH=7.0, 1 M NaCl, 20 mM imidazole, 0.5 mM DTT, 100 mM 
12 
EDTA), and then 10 mL of buffer A again. Purified protein was then eluted off the column in 
fractions with buffer C (20 mM sodium phosphate, pH=7.0, 0.5 mM DTT, 100 mM NaCl) 
supplemented with varying amounts of imidazole increasing from 100 mM to 300 mM. 
Fractions were analyzed by SDS-Page and those containing pure tau were pooled together. 
The protein was reduced with 5 mM DTT and precipitated by adding equal volume of 
methanol and incubating at -20 
o
C overnight. The resulting precipitated protein was then 
collected by centrifugation at 5,000 rpm at 4 
o
C for 45 min. 
3.2 Spin Labeling 
Tau was dissolved in 6 M guanidine hydrochloride and labeled by adding a 10 fold 
molar excess of spin label (1-oxyl-2,2,5,5,-tetramethylpyrroline-3-methyl) 
methanethiosulfonate (MTSL, Toronto Research Chemicals) or the diamagnetic analog of 
MTSL (1-Acetoxy-2,2,5,5,-tetramethyl-d-3-pyrroline-3-methyl) methanethiosulfonate 
(dMTSL, Toronto Research Chemicals). The labeling process was allowed to occur 
overnight at 4
o
C. Excess label was removed by a PD-10 desalting column (GE Healthcare) 
equilibrated with desired buffer. The protein was then concentrated by centrifugation with 
3kDa Amicon Ultra-4 Centrifugal Filters (Merck). Protein was then stored at -20°C. 
3.3 Tht Fluorescence 
 Tht fluorescence intensity was measured with a Tecan M220 Infinite Pro plate reader 
at the Biological Nanostructures Laboratory within the California NanoSystems Institute 
(University of California, Santa Barbara).  A 40uL sample volume was added to a Corning 
384 Flat Black low volume well plate and covered with black vinyl electrical tape to prevent 
evaporation.  A Fluorescence Intensity scan was run with excitation wavelength 450nm and 
emission wavelength 484nm. The excitation bandwidth was 9nm and emission bandwidth 
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was 20nm with an integration time of 20us.  Number of flashes was set to 25.   Readings 
were taken from the bottom and sampling was on a 1 min interval over a 16 hr period.  A 
500us settling time delay was applied.   
3.4 cw-EPR 
 Cw-EPR was acquired using a Bruker EMX X-Band spectrometer and dielectric 
(ER4123D) cavity.  The microwave source applied ~6 mW of power at 9.8 GHz using 0.3G 
modulation amplitude and sweep width of 150 gauss.  Samples of 3.5uL volume were 
transferred to a 0.6mm diameter quartz capillary and sealed with wax on both ends.  A 2-D 
EPR spectrum was then acquired stepping through time.  Tau 187 322C concentration was 
100uM, aggregation was induced with 25uM 11 kDa Heparin (Sigma Aldrich) in Phosphate 
Final buffer (20mM Sodium Phosphate, 100mM Sodium Chloride, 100uM EDTA, pH 7.0).  
3.5 Turbidity 
 Turbidity measurements were carried out using a 8 multi-cell cuvette with a 1cm path 
length.  A UV 1800 Shimadzu UV Spectrophotometer was used to acquire data at a 350nm 
wavelength.  Sample volume was 100uL. 
3.6 DEER Spectroscopy 
 DEER spectroscopy was carried out on doubly labeled tau with 75uM MTSL labeled 
tau and 825uM analog dMTSL labeled tau.  The 1:11 MTSL:analog dMTSL ratio is meant 
eliminate interference from inter-protein spin interactions.  Measurements were carried out in 
deuterated Phosphate Final buffer with 30wt% sucrose.  40uL samples were transferred to 
quartz sample tubes and flash frozen in liquid nitrogen.  DEER measurements were carried 
out at 85K using a Bruker ELEXSYS E580 X-band spectrometer and MS3 resonator.  A 
dead-time free four-pulse DEER sequence was used setting the pump pulse to the center of 
14 
the nitroxide spectrum and applying the observe pulse at 65 MHz higher frequency The pulse 
durations of the (p/2)obs, (p)obs, and (p)pump, were 16 ns, 32 ns and 12 ns respectively. The 
delay t1 was set to 200 ns while t2 would vary from 1 ms up to 2 ms depending on the sample. 
Distance distributions were analyzed using DEERanalysis2013. 
 
3.7 TEM 
 Aggregated tau solutions were fixed in 1.6% Gluteraldehyde (Electron Microscopy 
Sciences) for 15min. A TEM grid, FORMVAR Carbon film on 300 mesh copper (Electron 
Microscopy Sciences), was floated on 10uL of the fixed sample for 1min and then blotted on 
filter paper. The grid was touched to 10uL of Deionized water, blotted, touched to 10uL of 
the stain solution, 2% Uranyl Acetate, blotted and then floated on 10uL of 2% Uranyl 
Acetate (Electron Microscopy Sciences) for 1 minute before blotting and then setting aside to 
dry for 24hours. Imaging was carried out at room temperature using a JEOL JEM-1230 TEM 
at the UCSB NRI-MCDB Microscopy facility. 
IV. Results and Discussion 
15 
4.1 β-Sheet Content Appears Early in Aggregation Process 
 Tht fluorescence and turbidity measurements, Figure 5, provide time resolved 
methods of monitoring the appearance of β-sheet content, however, Tht does not inform on 
the type of aggregate species—i.e. early oligomer vs fibrils—and a minimalistic Tht sensitive 
structure is unknown.  Additionally, Tht is incapable of quantitatively informing on the 
population of tau embedded into β-sheet structure.  Turbidity is dependent on particle size 
and morphology but offers no details of the molecular structure.  Thus we apply cw-EPR to 
singly labeled tau protein which provides quantitative measurements of the tau population 
packed in parallel β-sheets.  This specific packing structure is denoted by the appearance of a 
characteristic single line component in the typical three line nitroxide EPR spectra, Figure 
3A, which is caused by close inter-spin distances of ~8 Å.
31, 37, 38
 The total population of 
spins involved in these close distance spin-exchange interactions can be quantified from EPR 
Figure 5:  Comparison of kinetic curves derived by turbidity and Tht fluorescence.  Sample 
conditions in both experiments 100uM Tau 187 322C, 25uM 11kDa heparin.  In 
fluorescent experiment Tht concentration was 40uM.  Fluorescence and turbidity 
measurement as described.  Curves were normalized by maximum signal intensity and 
initial intensity was set to zero. 
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line shape decomposition of a 100% spin labeled tau sample, independent of fibril or 
oligomer size which is not necessarily true of Tht.  Here we label Tau 187 with MTSL at the 
natural cysteine site 322 which has been previously demonstrated to exhibit spin-exchange 
upon aggregation into fibrils.
19, 39
     Prior to heparin addition the Tau 187 322C MTSL EPR 
spectrum can be fit by a 100% mobile component, Figure 6.  Line shape analysis of cw-EPR 
spectra immediately following heparin addition reveals spin-exchange interactions appear 
almost instantaneously.  Within ~5min of aggregation induction ~10% of tau molecules are 
already embedded in parallel β-sheet structure as shown by the tau population involved in 
spin-exchange interactions (labeled β-sheet in Figure 6).  The population of tau involved in 
spin-exchange interactions plateaus at ~65%, and an additional ~20% of tau has reduced spin 
label mobility.  The amount of β-sheet structure plateaus after ~300min, Figure 6, but 
turbidity and Tht fluorescence, Figure 5, both continue to exhibit increases in signal intensity 
well after formation of new β-sheet structure has stagnated.  This discrepancy further 
demonstrates turbidity and Tht fluorescence insensitivity to molecular scale structural 
changes and in the case of Tht fluorescence reiterates the uncertainty with regard to Tht 
binding principles.     
The nature of early aggregate species is subject to debate as some studies indicate 
early oligomers are simply minimalistic aggregates with the same structure as mature fibrils, 
whereas more recent studies suggests early oligomers are a conformationally distinct species 
which later convert into fibrils through structural rearrangement.
16, 40-44
  The cw-EPR data 
presented in Figure 6 unequivocally shows β-sheet structure forms during the earliest stages 
of aggregation well before fibrils are thought to exist.  Despite the appearance of β-sheet 
structure early in the aggregation process, immediately after addition of heparin there is a 
17 
significant population of spins which have reduced mobility but are not directly involved in 
spin-exchange as shown by the large interfacial population, Figure 6.  This could be 
indicative of rapid initial aggregation, resulting in reduced mobility of the spin label, which is 
followed by slower conversion to β-sheet structure as observed by the increase in spin-
exchange interactions.  This would be consistent with a model of aggregation which has 
nucleation followed by a structural rearrangement step.  If early oligomers are indeed 
structurally distinct from fibrils, is there a detectable difference in behavior?  The AD and tau 
community has become greatly interested in seeded aggregation, where pre-aggregates of tau 
are created and then added to naive tau.  Considerable evidence has been compiled indicating 
the systematic propagation of tau pathology during AD as being carried out by pre-
aggregates of tau.
21-28
  Thus we specifically wish to examine the relationship between the 
population of tau embedded in β-sheet structure and seeding efficacy as well as determine 
whether the early aggregates in Figure 6 are on path-way. 
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Figure 6:  Population plot of Tau 187 322C 100% MTSL labeled during aggregation compiled from line 
shape analysis of cw-EPR spectra. β-sheet contribution refers to population of spins involved in spin-
exchange interactions, while the interface  component refers to broadening of the EPR line shape due to 
other effects.   Note: 0 aggregation time is before heparin addition and is 100% mobile.  Experimental 
conditions: 100uM Tau 187 322C MTSL, 25uM 11kDa Heparin Phosphate Final Buffer 
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Figure 7:  A) Schematic of seeding strategy.  A seed stock was prepared with 100uM Tau 187 322C MTSL, 
40uM Tht solution and incubated with 25uM 11kDa Heparin.  Aliquots were removed at 5min, 2hrs, and 24hrs 
and flash frozen in liquid nitrogen.  Aliquots were later thawed on ice and mixed in a 1:1 ratio with a monomer 
stock consisting of 100uM Tau 187 322C MTSL and 40uM Tht.  The experiment was carried out in Phosphate 
Final Buffer.  Fluorescence was then measured as described in methods. B)Tht Fluorescence of seed experiment 
with 5min, 2hr, and 24hr seeds mixed 1:1 with tau monomer as described.  A control experiment consisting of 
the estimated residual heparin concentration was carried out mixing 100uM Tau 187 322C MTSL, 40uM Tht 
and 12.5uM Heparin in Phosphate Final Buffer.C) Same data as in B with emphasis on first hour of 
aggregation.  Data was normalized by subtracting off initial fluorescence intensity of first data point in order to 
more clearly show difference in kinetic rate of aggregation between samples.   
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4.2 Pre-aggregated Species and Fibrils are not catalytic relative to heparin 
The early appearance of β-sheet structure raises questions regarding the impact of 
early aggregate species on aggregation of naïve tau.  Previous in vitro studies of seeded 
aggregation have focused on showing proof of concept, qualitative effects of seed 
concentration, and investigating conformational seeding barriers but none have addressed the 
fundamental question regarding the ability of different pre-aggregate species to recruit 
monomeric tau into fibrils.
16, 29, 30
 In order to address this question we employ the general 
strategy outlined in Figure 7A, whereby a sample of tau is pre-aggregated with heparin, 
mixed in a 1:1 molar ratio with naive tau, and then monitored by Tht Fluorescence.  Pre-
aggregates with varying degrees of β-sheet content can be generated by modulating the 
incubation time with heparin.    The 1:1 mixing of pre-aggregates with naïve tau should 
dilute the influence of heparin and through comparison to a control comprising the expected 
residual heparin concentration it should be possible to isolate the effect of pre-aggregated 
seed species.   
The initial fluorescence intensity, Figure 7B, increases with incubation time of the 
pre-aggregated seeds, making apparent significant differences in the initial β-sheet content of 
the seed species.  The cw-EPR data, Figure 6, shows ~10% of tau embedded in β-sheet 
structure at 5min, ~50% at 2hrs and ~65% at 24hrs.  If Tht binding is linear with regard to 
parallel β-sheet structure the initial fluorescence intensity of the 2hr seeds should be 
approximately five times that of the 5min seeds and 24hr seeds should yield seven times the 
initial fluorescence of 5min seeds.  It is clear such a straightforward correlation does not hold 
as 2hr seeds show roughly double the initial fluorescence intensity and 24hr seeds yield five 
times the initial intensity of the 5min seed sample.  Therefore, we can conclude that Tht 
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fluorescence is non-linear with regard to parallel β-sheet content as quantified by cw-EPR.   
As aggregation proceeds a convergence to similar fluorescence intensity levels is observed 
across all samples, suggesting the extent of β-sheet content reaches a common amount 
independent of the initial seed species. This shows that Tht represents a quantifiable 
parameter, even if the exact nature of the species Tht intensity is measuring is unclear. 
Furthermore, these results confirm no additional irreversible off-pathway aggregates are 
created by the seeding process.  
At first glance, seeds appear to retard the aggregation kinetics as shown by 
comparison of the initial kinetic rates, best illustrated in Figure 7C where the curves have 
been normalized by initial fluorescence intensity in order to more easily visualize differences 
in the slope.  The unseeded sample shows the most rapid aggregation rate followed in order 
of increasing pre-aggregation time for the seed species.  This is an observation inconsistent 
with past studies which have demonstrated pre-aggregated seeds are able to increase 
aggregation kinetics and reduce lag phases.
16
 However, several key differences in 
experimental design hint at a possible explanation for this discrepancy.  In the study by 
Friedhoff, P et al. the total tau concentration was not kept constant and the addition of seeds 
increased the total tau concentration relative to the unseeded control, thus there is more tau 
available to aggregate in their seeded vs unseeded experiments.
16
  In our experimental design 
total tau concentration is held constant across all experiments.  We suspect the differences in 
kinetic rate is not due to the seeds but rather to differences in the amount of tau available to 
aggregate, e.g. if we assume 24hr seeds are 65% aggregated initially (from Figure 6) and the 
heparin control is initially 0% aggregated (Figure 6) then the 24hr seed experiment would 
have 73.5% of tau available to aggregate and the heparin control would have 100% of tau 
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available to aggregate.  A compounding factor which makes this difficult to directly assess 
from Tht Fluorescence is the non-linearity of fluorescence with respect to β-sheet structure as 
demonstrated by comparison of initial seed fluorescence intensity with cw-EPR.  Therefore 
to draw a definitive conclusion would require conducting similar seeding experiments with 
cw-EPR as this would provide a direct measure of tau populations.  Kinetic rates could then 
be measured based on the appearance of specific structural features rather than depend on a 
qualitative fluorescent marker.  If differences in kinetic rate are indeed tied to available tau in 
solution, then it is heparin that ultimately is controlling the aggregation behavior and the 
effect of pre-aggregated seeds is being masked or overridden.  Thus our next step is to 
examine the potency of heparin in promoting aggregation of tau. 
4.3 Minute Amounts of Heparin are Capable of Extending Tau 
Figure 8:  DEER distance distribution.  Center of distribution represents average distance between 
attached spin labels. Tau 187 G272C/S284C MTSL 75uM, Tau187 G272C/S284C analog dMTSL 
825uM, 11kDa Heparin various molar ratios, 30wt% sucrose in Phosphate Final Buffer in D2O.  
Sampels aggregated for 1 hour and then flash frozen in liquid nitrogen.  Measurement was carried 
out at 85 K.  Inset schematic of extension from compact to extended state 
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 The ability of heparin to override or mask the effect of pre-aggregated species as 
demonstrated in Figure 7 leads us to question the potency of heparin as a promoter of tau 
aggregation.  Our group has identified a conformational shift around the PHF6* hexapeptide 
from a compact to an extended state, Figure 8 schematic, induced by mixing with heparin.  In 
this work we specifically wish to address the nature of the tau-heparin interaction by 
examining the effect of stoichiometry on the aggregation process, hypothesizing that if 
heparin is acting in a catalytic like capacity then there should be no stoichiometric effect of 
heparin on the extension around PHF6* at least down to an unknown catalytic threshold.  
DEER spectroscopy contradicts this hypothesis as extension exhibits a stoichiometric 
dependence on heparin.  A 4:1 tau:heparin ratio induces a more dramatic observable distance 
change compared to 40:1 or 80:1 ratio, Figure 8.  Extension around the PHF6* hexapeptide is 
still observed at more dilute conditions, although the effect is reduced.  Whether this 
reduction in extension distance is due to a smaller population being affected or resultant from 
a similar population undergoing a smaller conformational shift cannot be determined from 
DEER spectroscopy.  A similar distance change is observed in both the 40:1 and 80:1 case so 
it does not appear that the stoichiometric dependence is linear.   Commonly, a 4:1 molar ratio 
of tau:heparin is considered optimal for tau aggregation but our results show heparin is 
capable of inducing conformational rearrangement even at dilute conditions.
14
 To further 
examine the stoichiometric effect of heparin we employ Tht to qualitatively examine the 
effect on tau aggregation kinetics.       
4.4 Heparin Stoichiometry Dictates Total Amount of Fibril Content 
 Evidence from Figure 8 suggests a stoichiometric dependence between heparin and 
tau conformation around the PHF6* hexapeptide, but how does this dependence manifests in 
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the aggregation kinetics?  Tht fluorescence exhibits a dependence on heparin stoichiometry, 
Figure 9, as higher heparin concentrations result in increased fluorescence and thus indicate 
increased fibril content, although cw-EPR would be required to quantify the exact differences 
in β-sheet amount.  The dependence of observed distance change on heparin stoichiometry 
shown in Figure 8 has two possible explanations: 1) A smaller population of tau is extending, 
but the extension distance does not depend on heparin stoichiometry. 2) A similar tau 
population is affected but a lower heparin stoichiometry reduces how much tau extends.  The 
results from Figure 9 seem to support the former explanation as a smaller amount of tau is 
involved in Tht active fibril formations at lower heparin concentrations.  The fact that the 
amount of extension, Figure 8, correlates to the amount of fibril content, Figure 9, offers 
additional, though not conclusive, support to our hypothesis that the extension around the 
PHF6* hexapeptide is a critical step in the aggregation process. 
The dependence of fibril content on heparin stoichiometry, Figure 9, corroborates a 
study by Ramachandran, G., and Udgaonkar, J. B.
45
  They contribute this effect to a 
Figure 9: Tht Fluorescence of tau aggregation carried out at various tau:heparin stoichiometries.  100uM Tau 
187 322C MTSL, 40uM Tht in Phosphate Final Buffer mixed with various concentrations of 11kDa Heparin.  
Tht fluorescence carried out as described. 
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stoichiometric complexation between tau and heparin in a 2:1 stoichiometric ratio.  However, 
our observation of 40:1 and 80:1 tau:heparin ratios exhibiting similar distance changes, 
Figure 8, suggests a non-linear dependence of conformational rearrangement on 
stoichiometry thus an argument based on a defined tau:heparin complexation ratio seems too 
simplistic. Cw-EPR could provide some clarity in this regard by determining the precise 
dependence of parallel β-sheet structure on heparin stoichiometry, whereas Tht fluorescence 
is only capable of highlighting qualitative differences.  Total fibril content and tau 
conformation both depend on heparin stoichiometry, but this dependence does not appear 
explainable by simple correlations and the tau-heparin relationship remains quite complex.   
  V. Conclusions 
 In this work we have examined the appearance of parallel β-sheet structure through a 
combination of Tht fluorescence, turbidity and cw-EPR.  Our work demonstrates the 
drawbacks of Tht fluorescence and turbidity in sensitivity to molecular level details 
compared to cw-EPR which is capable of monitoring specific structural details of the 
aggregation system.  As shown by our data in Figure 6 a small amount of β-sheet content 
appears immediately after heparin addition in conjuncture with a spike in the population of 
spins suffering decreased mobility. The following increase in spin-exchange interactions 
during aggregation is consistent with proposed models of aggregation which have initial 
nucleation followed by a structural rearrangement step.  Subsequent seeding experiments 
corroborated early appearance of β-sheet structure but also showed Tht fluorescence to be 
non-linear with respect to β-sheet content measured by cw-EPR.  Additionally, seeds do not 
affect end stage total fibril content.  Differences in aggregation kinetics appear to be 
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dependent on the amount of tau available for aggregation and any effects of seeds on kinetic 
rate appear to be overridden by heparin. 
 The application of DEER spectroscopy revealed a stoichiometric dependence of tau 
conformational rearrangement around the PHF6* hexapeptide on heparin, however, even 
dilute heparin concentrations proved capable of inducing significant distance changes 
although the effect was reduced.  The distance change dependence on stoichiometry appears 
to be non-linear as indicated by similar distance changes being observed at separate 
stoichiometries (40:1 and 80:1).  Additionally, Tht fluorescence indicates a firm dependence 
between the total amount of fibril content and heparin stoichiometry.  To quantitatively 
determine the exact dependence between β-sheet structure and heparin stoichiometry would 
require further investigation by cw-EPR.  From our study it appears the nature of the tau-
heparin aggregation system is quite complex and significant additional effort will be required 
to reach a full understanding.    
VI. Future Work 
Establishing the relationship between pre-aggregate seed structure and efficacy at 
recruiting naïve tau to aggregate is still an outstanding question of great importance to the 
field.  Our work here has established the potency of heparin in controlling the aggregation of 
tau in vitro as heparin stoichiometry controls tau conformation rearrangement even at dilute 
quantities.  Therefore it is necessary to find a method of removing heparin from pre-formed 
seeds or alternatively find a suitable method of creating seeds without using an induction 
cofactor.  It has been reported that a disease mutant of tau, ΔK280, can be aggregated at 
experimentally relevant time scales through application of heat, thus aggregates formed from 
this ΔK280 mutant would be a good candidate for isolating the effect of seeds on kinetics.46  
27 
Finally, our work here has demonstrated the utility of cw-EPR to track aggregation kinetics 
as it provides molecular level resolution about the spin label environment.  In future studies 
we should take advantage of these capabilities where quantitative population measurements 
are desirable. 
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